Treating Patients in the Age of Fentanyl, Xylazine, and Novel Potent Opioids: A Practice Guide on How to Treat Patients and Reduce Harm

Description

This is a 90-minute training to discuss the pathophysiology of substance use with a focus on fentanyl and xylazine in WNC. This presentation will focus primarily on educating ER providers on the situation in WNC and the best tactics and techniques to care for incoming patients.

MAHEC engages in evaluation activities to better understand the impact of our programs. By registering for this course, you agree that we may use your personal information in evaluative research regarding this program. Any reports published will be de-identified and reported in aggregate format.

By registering for this program, you are granting permission for your contact information to be shared with the North Carolina Healthcare Foundation, supporters of this continuing education activity.

With Support From

Target Audience

This program has been developed for ER hospital staff and others interested in this subject

Objectives

• Describe the pathophysiology of substance use, specifically with increasing prevalence of fentanyl and xylazine in WNC
• Foster confidence and comfort with an accessible practice across a variety of spectrums, from harm reduction to primary care
• Discuss how to support & educate patients to apply harm-reduction management techniques

Faculty

• Genevieve Verrastro, MD